PHATHOM PHARMACEUTICALS, INC. (PHAT) Net Margin
- 2026-06-30: Net Margin -23.67%.
- 2026-03-31: Net Margin -52.09%.
- 2025-12-31: Net Margin -36.73%.
- 2025-09-30: Net Margin -60.55%.
Complete source-backed net margin history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -23.67% |
| 2026-03-31 | -52.09% |
| 2025-12-31 | -36.73% |
| 2025-09-30 | -60.55% |
| 2025-06-30 | -191.91% |
| 2025-03-31 | -330.71% |
| 2024-12-31 | -250.98% |
| 2024-09-30 | -523.34% |
| 2024-06-30 | -1248.58% |
| 2024-03-31 | -4333.26% |
| 2023-12-31 | -11667.16% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -126.35% |
| 2024-12-31 | -605.09% |
| 2023-12-31 | -29558.94% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |